I broadly work on making biological systems more programmable. This started with an interest in polypharmacology, where I trained large chemistry models to design tool compounds that promote stress resilience in cell therapy manufacturing contexts. I’ve also spent time making AI useful in more traditional biotech applications across oncology, substance abuse disorders, and neurodegeneration. Now, I work on reasoning models to help underwrite therapeutics bets with the highest transformational potential.